NT‐proBNP by Itself Predicts Death and Cardiovascular Events in High‐Risk Patients With Type 2 Diabetes Mellitus

Background NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) improves the discriminatory ability of risk‐prediction models in type 2 diabetes mellitus (T2DM) but is not yet used in clinical practice. We assessed the discriminatory strength of NT‐proBNP by itself for death and cardiovascular even...

Full description

Bibliographic Details
Main Authors: Marcus V. B. Malachias, Pardeep S. Jhund, Brian L. Claggett, Magnus O. Wijkman, Rhonda Bentley‐Lewis, Nishi Chaturvedi, Akshay S. Desai, Steven M. Haffner, Hans‐Henrik Parving, Margaret F. Prescott, Scott D. Solomon, Dick De Zeeuw, John J. V. McMurray, Marc A. Pfeffer
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.017462